School of Medicine
Showing 181-200 of 538 Results
-
Joyce Teng, MD, PhD
Professor of Dermatology and, by courtesy, of Pediatrics
BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Valerie Teng
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Valerie Teng is a board certified family physician with special interests in preventative medicine and women's health. Her experiences in caring for patients with chronic conditions, such as diabetes and hypertension, have fueled her desire to partner with patients to enter healthier lifestyles. She is also passionate about providing comprehensive care to patients of all ages, including newborns and teens.
During her residency training, Dr. Teng explored many opportunities in medical education through the O’Connor-Stanford Leaders in Education Residency (OSLER) program. She is delighted to continue in medical education as a part of the faculty at Stanford Family Medicine. -
Stefano Testa, MD
Instructor, Medicine - Oncology
BioDr. Stefano Testa is a board-certified, fellowship-trained medical oncologist with Stanford Health Care. He is also a clinical instructor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Testa specializes in treating patients with sarcomas and other solid tumors using cellular therapy approaches. He has expertise in adoptive T-cell therapies, including chimeric antigen receptor T-cell (CAR-T) and T-cell receptor (TCR) therapies.
As a physician-scientist, Dr. Testa focuses on developing next-generation cellular therapies for solid tumors, particularly sarcomas. His research goal is to identify targets for adoptive T-cell therapies in solid tumors, including soft tissue and bone sarcomas, and on novel synthetic biology approaches to enhance the effectiveness of T-cell therapies against solid tumors.
Dr. Testa has authored numerous peer-reviewed publications in leading medical journals, including Immunity, Cancer Discovery, JAMA Network Open, Genome Medicine, and Biomacromolecules. He has presented his research at national and international scientific meetings, including the Connective Tissue Oncology Society Annual Meeting and the Society for Immunotherapy of Cancer Annual Meeting.
Dr. Testa is a member of the American Society of Clinical Oncology (ASCO), Connective Tissue Oncology Society (CTOS), the American Society of Hematology (ASH), and the Society for Immunotherapy of Cancer (SITC).
